Anticancer activity of osmium metalla-rectangles

Area of Science:

• Coordination Chemistry
• Organometallic Chemistry
• Materials Science
• Medicinal Chemistry

Background:

• Development of novel metal-based anticancer agents is crucial for overcoming drug resistance.
• Osmium complexes offer unique electronic and structural properties for therapeutic applications.
• Metalla-rectangles represent a promising class of supramolecular architectures for drug delivery and therapy.

Purpose of the Study:

• To synthesize and characterize novel cationic osmium metalla-rectangles.
• To evaluate the in vitro cytotoxic activity of these complexes against ovarian cancer cell lines.
• To compare the efficacy of the most active complex with cisplatin, including against cisplatin-resistant cells.

Main Methods:

• Synthesis of dinuclear arene osmium precursors.
• Reaction with bipyridine linkers in the presence of silver triflate to form tetranuclear metalla-rectangles.
• Characterization using NMR, IR, and UV-visible spectroscopy.
• Cytotoxicity assays using A2780 and A2780cisR ovarian cancer cell lines.

Main Results:

• Successful synthesis of cationic tetranuclear osmium metalla-rectangles with general formula [(p-cymene)(4)Os(4)(OO[intersection]OO)(2)(N[intersection]N)(2)](4+).
• The complex [(p-cymene)(4)Os(4)(dhbq)(2)(4,4'-bipyridine)(2)](4+) exhibited potent cytotoxicity with an IC(50) of 5.7 microM against A2780 cells.
• This lead compound also showed significant activity against cisplatin-resistant A2780cisR cells (IC(50) = 7.5 microM), comparable to cisplatin.

Conclusions:

• Cationic osmium metalla-rectangles represent a new class of potential anticancer agents.
• The synthesized metalla-rectangles demonstrate significant cytotoxic effects against ovarian cancer cells.
• The lead compound shows promise for treating both cisplatin-sensitive and cisplatin-resistant ovarian cancers.